NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 273 filers reported holding NEOGENOMICS INC in Q1 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $130,000 | +3.2% | 15,124 | -1.9% | 0.00% | 0.0% |
| Q2 2022 | $126,000 | -26.3% | 15,424 | +9.6% | 0.00% | 0.0% |
| Q1 2022 | $171,000 | -73.7% | 14,069 | -26.1% | 0.00% | -80.0% |
| Q4 2021 | $649,000 | -32.4% | 19,029 | -4.4% | 0.01% | -16.7% |
| Q3 2021 | $960,000 | +27.8% | 19,904 | +19.7% | 0.01% | -14.3% |
| Q2 2021 | $751,000 | +5.0% | 16,629 | +12.1% | 0.01% | 0.0% |
| Q1 2021 | $715,000 | -51.1% | 14,829 | -45.4% | 0.01% | -53.3% |
| Q4 2020 | $1,463,000 | +82.6% | 27,181 | +25.1% | 0.02% | +50.0% |
| Q3 2020 | $801,000 | +29.8% | 21,725 | +9.1% | 0.01% | +11.1% |
| Q2 2020 | $617,000 | +17.3% | 19,915 | +4.6% | 0.01% | -10.0% |
| Q1 2020 | $526,000 | -2.6% | 19,035 | +3.2% | 0.01% | +25.0% |
| Q4 2019 | $540,000 | +176.9% | 18,446 | +80.9% | 0.01% | +166.7% |
| Q3 2019 | $195,000 | – | 10,194 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,615,513 | $13,166,000 | 9.25% |
| First Light Asset Management, LLC | 2,715,487 | $22,131,000 | 2.58% |
| PERKINS CAPITAL MANAGEMENT INC | 202,550 | $1,651,000 | 1.71% |
| Greenhouse Funds LLLP | 1,395,035 | $11,370,000 | 1.25% |
| EMERALD ADVISERS, LLC | 1,213,353 | $9,889,000 | 0.51% |
| Bullseye Asset Management LLC | 108,272 | $883,000 | 0.50% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 959,858 | $7,823,000 | 0.45% |
| OAK FAMILY ADVISORS, LLC | 88,604 | $722,000 | 0.36% |
| MPM BioImpact LLC | 135,573 | $1,105,000 | 0.31% |
| Fernwood Investment Management, LLC | 70,285 | $573,000 | 0.25% |